person · Reporting owner
Anderson Ray Benjamin M
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | Director | March 03, 2022 | March 07, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date March 03, 2022 · Filed March 07, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectTrust | 0 |
Reported balance
After 2022-03-03 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2022-03-03 · Sale · Disposed 4,516 · Balance 0 F1: Represents the weighted average share price of an aggregate total of 4,516 shares sold in the price range of $34.30 to $35.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2: Shares sold by the Benjamin M. Anderson-Ray Revocable Living Trust (the "Trust"), a trust for the benefit of the Reporting Person and his spouse, and for which the Reporting Person has shared voting and investment power with respect to the shares held by the Trust. |
| Common StockSEC Table I · non-derivative | Direct | 10,775 |
Reported balance
Holding disclosure · report date 2022-03-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 10,775 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average share price of an aggregate total of 4,516 shares sold in the price range of $34.30 to $35.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Shares sold by the Benjamin M. Anderson-Ray Revocable Living Trust (the "Trust"), a trust for the benefit of the Reporting Person and his spouse, and for which the Reporting Person has shared voting and investment power with respect to the shares held by the Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2022 Filed Mar 7, 2022 23:57 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,516 | $34.68 | $156,618.94 |
DisclosureSEC source: 0001209191-22-016841 · doc4.xml · nonDerivative · entry 2 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F1 · price: Represents the weighted average share price of an aggregate total of 4,516 shares sold in the price range of $34.30 to $35.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Shares sold by the Benjamin M. Anderson-Ray Revocable Living Trust (the "Trust"), a trust for the benefit of the Reporting Person and his spouse, and for which the Reporting Person has shared voting and investment power with respect to the shares held by the Trust. Read SEC document |
| May 10, 2021 Filed May 12, 2021 23:43 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032216 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,775 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 11, 2020 Filed May 12, 2020 22:40 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 4,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-028634 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,021 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the Reporting Person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 09, 2019 Filed May 10, 2019 20:47 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-028978 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,463 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 09, 2019 Filed May 22, 2019 00:50 UTC Amendment | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031879 · doc4a.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 20:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001209191-18-053202 · doc4.xml · derivative · entry 4 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 1,000 shares Expires 2022-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is October 14, 2015. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 20:38 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,000 | $246.22 | $246,220.00 |
DisclosureSEC source: 0001209191-18-053202 · doc4.xml · nonDerivative · entry 2 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2017. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 20:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $43.21 | $43,210.00 |
DisclosureSEC source: 0001209191-18-053202 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001209191-18-041266 · doc4.xml · derivative · entry 4 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,000 shares Expires 2022-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is October 14, 2015. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:41 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,000 | $184.88 | $184,880.00 |
DisclosureSEC source: 0001209191-18-041266 · doc4.xml · nonDerivative · entry 2 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2017. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $43.21 | $43,210.00 |
DisclosureSEC source: 0001209191-18-041266 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:38 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 989 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-029863 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 22:13 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001209191-18-025638 · doc4.xml · derivative · entry 4 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 1,000 shares Expires 2022-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is October 14, 2015. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 22:13 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,000 | $139.82 | $139,820.00 |
DisclosureSEC source: 0001209191-18-025638 · doc4.xml · nonDerivative · entry 2 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2017. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 22:13 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $43.21 | $43,210.00 |
DisclosureSEC source: 0001209191-18-025638 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 00:34 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $43.21 | $0.00 |
DisclosureSEC source: 0001209191-18-001518 · doc4.xml · derivative · entry 4 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 1,000 shares Expires 2022-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is October 14, 2015. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 00:34 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,000 | $119.06 | $119,060.00 |
DisclosureSEC source: 0001209191-18-001518 · doc4.xml · nonDerivative · entry 2 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 00:34 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $43.21 | $43,210.00 |
DisclosureSEC source: 0001209191-18-001518 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2017 Filed Dec 29, 2017 21:29 UTC | Inogen Inc INGN · Entity 2083 | GiftCommon Stock | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067636 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,516 F1 · ownership.nature: Shares held of record by the Benjamin M. Anderson-Ray Revocable Living Trust (the "Trust"), of which the reporting person and his spouse are the trustees and beneficiaries. The reporting person has shared voting and investment power with respect to the shares held of record by the Trust. Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:34 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,445 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-17-034513 · doc4.xml · derivative · entry 4 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,445 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/24th of the total shares subject to the option shall vest every month after April 1, 2014. F4 · derivative.expiration_date: Previous Forms 4 indicated an incorrect expiration date. Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:34 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,445 | $81.05 | $360,271.25 |
DisclosureSEC source: 0001209191-17-034513 · doc4.xml · nonDerivative · entry 2 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Represents the weighted average share price of an aggregate total of 4,445 shares sold in the price range of $81.00 to $81.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:34 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,445 | $16.62 | $73,875.90 |
DisclosureSEC source: 0001209191-17-034513 · doc4.xml · nonDerivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2017 Filed May 12, 2017 17:24 UTC | Inogen Inc INGN · Entity 2083 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $83.30 | $0.00 |
DisclosureSEC source: 0001209191-17-031801 · doc4.xml · derivative · entry 1 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-05-10 F1 · derivative.exercise_date: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but will vest fully on the date of the next Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is May 11, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.